Cargando…
Advances in Gene Therapy Techniques to Treat LRRK2 Gene Mutation
Leucine-rich repeat kinase 2 (LRRK2) gene mutation is an autosomal dominant mutation associated with Parkinson’s disease (PD). Among LRRK2 gene mutations, the LRRK2 G2019S mutation is frequently involved in PD onset. Currently, diverse gene correction tools such as zinc finger nucleases (ZFNs), help...
Autores principales: | Chung, Sun-Ku, Lee, Seo-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775085/ https://www.ncbi.nlm.nih.gov/pubmed/36551242 http://dx.doi.org/10.3390/biom12121814 |
Ejemplares similares
-
The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014) -
Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
por: Nazish, Iqra, et al.
Publicado: (2023) -
Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations
por: Lee, Seo-Young, et al.
Publicado: (2016) -
Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons
por: Kim, Hyejung, et al.
Publicado: (2021) -
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review
por: Chen, Meng-Ling, et al.
Publicado: (2018)